A Retrospective Interventional Cohort Study to Assess the Safety and Efficacy of Sandostatin LAR for Treatment of Recurrent and/or Refractory Meningiomas

A Retrospective Interventional Cohort Study to Assess the Safety and Efficacy of Sandostatin LAR for Treatment of Recurrent and/or Refractory Meningiomas

Background: Meningiomas are the most common adult primary intracranial tumors in the United States. Despite high recurrence rate of atypical and malignant subtypes, there is no approved drug indicated specifically for meningioma. Since the majority of meningiomas exhibit high density of somatostatin...

Full description

Bibliographic Details
Main Authors: Maya Hrachova, Emely Nhi T. Nguyen, Beverly D. Fu, Manisha J. Dandekar, Xiao-Tang Kong, Gilbert Cadena, Frank P. K. Hsu, John Billimek, Thomas H. Taylor, Daniela A. Bota
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Neurology
Subjects:
recurrent progressive meningioma
Somatostatin LAR
octreotide
skull based meningioma
meningioma size
meningioma surgery
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2020.00373/full

Internet

https://www.frontiersin.org/article/10.3389/fneur.2020.00373/full

Similar Items